Navigation Links
Medarex Announces Election of Marc Rubin as New Board Member
Date:11/7/2007

PRINCETON, N.J., Nov. 7 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX) today announced that Marc Rubin, M.D. has been elected by the company's Board of Directors to serve as a director on Medarex's Board, effective November 1, 2007.

Dr. Rubin is President and CEO of Titan Pharmaceutical, Inc., a biopharmaceutical company publicly traded on the American Stock Exchange. Prior to joining Titan in October 2007, he was Head of Global Research and Development for Bayer Schering Pharma and a member of the Executive Committee of Bayer Healthcare and the Board of Management of Bayer Schering Pharma. Prior to his position at Bayer Schering Pharma, Dr. Rubin was a Member of the Executive Board and President of Development for Schering AG, as well as Chairman of Schering Berlin Inc. and President of Berlex Pharmaceuticals, a division of Schering AG. His position included responsibility for three Global Business Units. Before joining Schering AG, Dr. Rubin held several positions of increasing responsibility at GlaxoSmithKline, including oversight of the development, approval and commercial strategy for numerous programs. Dr. Rubin completed his clinical training in internal medicine at The Johns Hopkins Hospital and subspecialty training in both oncology and infectious disease at the National Institutes of Health. He received his M.D. from Cornell University Medical College and did his undergraduate work at Cornell University.

"We are very pleased Marc is joining our Board of Directors," said Howard H. Pien, President and CEO of Medarex. "He brings strong industry experience to our Board which will complement the Board's leadership in continuing to guide the company's future growth strategy and value creation."
'/>"/>

SOURCE Medarex
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Medarex to Present at Thomas Weisel Partners Healthcare Conference 2007
2. Medarex to Present at the Bear Stearns 20th Annual Healthcare Conference
3. Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
4. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
5. Medarex to Present at the UBS Global Life Sciences Conference
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013 PathoGenetix, Inc. , ... rapid bacterial strain typing, announced today that John ... as Vice President of Engineering. Dr. Luckey will ... RESOLUTION™ Microbial Genotyping System . The fully ... pathogen-specific assay kits, database and software, will be ...
(Date:6/18/2013)... DC (PRWEB) June 18, 2013 On ... Services (CMS) released a final decision memorandum concluding ... to guide subsequent management of anti-tumor strategy, and ... collection. The National Oncological PET Registry (NOPR) was developed ... the first projects under the Coverage with Evidence Development ...
(Date:6/17/2013)... MA (PRWEB) June 17, 2013 ... system in March that helps better monitor potentially harmful ... The microAnalyzer V2.0, which was developed by Draper ... Space Station. , Astronauts breathe air that is processed ... to harmful compounds in the air, even in trace ...
(Date:6/17/2013)... 2013 The Defense Threat Reduction Agency ... at the Waterford in Springfield, Virginia on July 22-25 ... will present technical details on their counter weapons of ... broad range of counter WMD areas including: (1) Science ... Science; (3) Science for Protection; (4) Science to Defeat ...
Breaking Biology Technology:PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 2PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 3WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 2WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 3New Monitoring System Will Better Protect NASA Astronauts on ISS 2Invitation to Register: Annual Defense Threat Reduction Agency Basic Research Technical Review 2
... 2007 -, - Tests Delivered Grew 68 Percent Compared to ... - Conference Call Today at ... Health,Inc. (Nasdaq: GHDX ) today reported financial results and business progress,for ... million in the first quarter of 2008,compared to $14.1 million in the ...
... Pfizer Enterprise 2.0 expert, to deliver keynote address ... ... Pa., May 6 Simon Revell, Manager of Enterprise,2.0 Technology ... Web 2.0,social software can be leveraged to stimulate the advancement ...
... Awards with ,Blue Ladies, a, Masterpiece of a ... CHICAGO, May 6 AbelsonTaylor, long known ... top honors in the medical device category at ... awards ceremony was part of,the DTC National Conference ...
Cached Biology Technology:Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 2Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 3Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 4Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 5Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 6Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 7Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 8Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 9Hershey Center for Applied Research Supports Acceleration of Scientific Research and Development 2Hershey Center for Applied Research Supports Acceleration of Scientific Research and Development 3AbelsonTaylor Captures DTC Gold 2AbelsonTaylor Captures DTC Gold 3
(Date:6/18/2013)... $12.7 million to match nine academic research groups ... explore new treatments for patients in eight disease ... schizophrenia. The collaborative pilot initiative, called Discovering New ... the National Center for Advancing Translational Sciences (NCATS) ... The process of developing a new therapeutic is ...
(Date:6/18/2013)... chemical modification of DNA and this modification can ... sequence. Until now, scientists believed that this epigenetic ... Today, a team of researchers from the University ... Louis-Jeantet Professor at the Faculty of Medicine, reveals ... that DNA methylation may play both a passive ...
(Date:6/17/2013)... new virus in patients with severe brain infections in ... virus is responsible for the symptoms of disease. , ... out of 644 patients with severe brain infections in ... any of the 122 patients with non-infectious brain disorders ... central nervous system are often fatal and patients who ...
Breaking Biology News(10 mins):NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4The secret of DNA methylation 2New virus isolated from patients with severe brain infections 2New virus isolated from patients with severe brain infections 3
... Charlie Kerfoot,s doughnut, and all fingers point to a European ... No one knew about the doughnut in southern Lake Michigan, ... Charles Kerfoot and his research team first saw it in ... their research vessels on any of the shipwreck-studded Great Lakes ...
... 17, 2010Colon cancer is the second most common cancer in ... year. It has been known for some time that mutations ... of all sporadic colon cancers. Now researchers at Huntsman Cancer ... featured today in Cell the mechanism by which mutation of ...
... We run our modern lives largely by the clock, from ... herald each new workday to the watches and clocks that ... the like. In addition to those ubiquitous timekeepers, ... biological machinery and which help set our circadian rhythms, regulating ...
Cached Biology News:Death of the 'doughnut' 2Death of the 'doughnut' 3Mechanism behind demethylation pinpointed in APC gene mutants 2Tick tock: Rods help set internal clocks, biologist says 2
Mouse monoclonal antibody raised against a full length recombinant PPIL2. NCBI Entrez Gene ID = PPIL2...
Mouse monoclonal antibody raised against a full length recombinant SCGB3A2. NCBI Entrez Gene ID = SCGB3A2...
Mouse polyclonal antibody to BAG2 - BCL2-associated athanogene 2...
Mouse monoclonal antibody raised against a partial recombinant QPCT. NCBI Entrez Gene ID = QPCT...
Biology Products: